News

Treatment with the investigational anti-IgE biologic ligelizumab was generally effective in patients with H1 antihistamine-unresponsive chronic spontaneous urticaria (CSU) who did not achieve complete symptom control with omalizumab (Xolair), an exploratory analysis of a phase IIb extension study showed. In a subset of omalizumab-treated patients with a score greater than 0 on the 7-day urticaria
0 Comments
It’s been more than 12 years since a reporter from Allure magazine sounded alarms about the Brazilian Blowout hair treatment, a salon product that offered frizz-free hair straightening that would last for two to three months. The technique worked really well if you wanted shiny, pin-straight hair—but it also had terrible fumes that many stylists
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Several dozen Secret Service officers have tested positive for the coronavirus or are in self-isolation after coming into close contact with someone who has tested positive. Several news outlets have reported different numbers — with potentially more than 130 officers infected
0 Comments
For a cyber criminal, healthcare records are one-stop shopping. Sell a Social Security number? Of course. Credit card numbers: They’re good on the black market, too. And for those criminals who love scams, there are phone numbers, email addresses, birthdays.  And of course there is always blackmail, which is what happened to psychotherapy patients in Finland whose
0 Comments
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of the fixed-dose combination of latanoprost and netarsudil (Roclanda). The ophthalmic solution is indicated to decrease elevated intraocular pressure (IOP) in adults with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil fails, according
0 Comments
Welcome to Telehealth Roundup, highlighting news and features about emerging trends in telemedicine and telehealth. What Doctors Need From Telemedicine Well before the telehealth explosion, doctors were experiencing what “neuroscientist Adam Gazzaley called a ‘cognition crisis,’ with excess screen time and corresponding information overload leading to digital fatigue and stress,” said radiologist Ashwini Zenooz, MD,
0 Comments
With Thanksgiving arriving in two weeks, families are making holiday plans. While some will share Thanksgiving dinner with their household, others hope to travel out of state to be with friends and loved ones. In the pre-pandemic world, it’s likely most didn’t think twice about flying long distances for the holidays. But in 2020, many have decided not to fly
0 Comments
About one-third of patients with chronic hepatitis B maintained a profile consistent with inactive disease 1 year after withdrawal from treatment in the randomized HBRN trial, which compared tenofovir with and without pegylated interferon (PEG-IFN). The two treatment groups, however, had similarly low rates of hepatitis B surface antigen (HBsAg) loss, the trial’s primary end point. The successful
0 Comments
For many, Thanksgiving means gathering around the dinner table with people they love, sharing food and friendship, maybe some politics, while filling and refilling plates and glasses. This year, however, to no one’s surprise, public health officials are suggesting caution-saturated contact. After enduring months of isolation, how can people manage to stay safe and be together on the holiday? (If
0 Comments
Ticagrelor failed to unseat clopidogrel as the guideline-recommended P2Y12 inhibitor of choice in patients undergoing elective percutaneous coronary intervention for stable CAD in the randomized ALPHEUS trial. “The higher level of platelet inhibition obtained with ticagrelor does not translate into a reduction of periprocedural MI or myocardial injury within 48 hours of high-risk PCI performed
0 Comments
Patients can use an optical coherence tomography (OCT) device at home to accurately identify retinal fluid caused by neovascular age-related macular degeneration (nAMD), researchers say. Paired with artificial intelligence (AI), the home OCT device could allow clinicians to monitor the fluid more continuously while reducing the number of office visits needed, said Anat Loewenstein, MD,
0 Comments
Early in the pandemic, problems caused by regulatory roadblocks to mobility and professional practice for nurses, doctors, and other healthcare professionals became abundantly clear, with the realization that they could jeopardize diagnosis and treatment of COVID-19 patients. Many states issued executive emergency orders allowing a more nimble response that included speeding up how to get
0 Comments
The raging opioid epidemic in the United States should prompt eye doctors to cast a suspicious gaze on patients seeking care for red and inflamed eyes, which could signal a problem far worse than a minor eye infection.  That’s the conclusion of ophthalmologists whose new research revealed a 400% increase in hospitalizations among drug users
0 Comments
Social media networks have become highly effective marketing platforms for many businesses, including medical and healthcare companies. Medical businesses use social media networks, such as Instagram, to promote their products and services to individual consumers. This makes it easy for them to accumulate thousands of Instagram followers.  People today use the internet to learn virtually
0 Comments
Novel oral agent omecamtiv mecarbil modestly reduced heart failure events in heart failure with reduced ejection fraction (HFrEF) atop usual therapies, according to the GALACTIC-HF trial. The primary endpoint of combined cardiovascular death and hospitalization or other urgent treatment for heart failure occurred in 37.0% of omecamtiv mecarbil recipients over a median 21.8 months, compared
0 Comments
A new app, designed for high-risk cancer patients, helps them and their physicians weigh the risks and benefits of delaying chemotherapy should the risk of contracting Covid-19 while getting their treatment is high.  According to STAT news, the app can show oncologists and patients whether immediate treatment could improve or hurt their chances of survival post-treatment. Developed by the University
0 Comments
For many, Thanksgiving means gathering around the dinner table with people they love, sharing food and friendship, maybe some politics, while filling and refilling plates and glasses. This year, however, to no one’s surprise, public health officials are suggesting caution. After enduring months of isolation, how can people manage to stay safe and be together on the holiday? (If
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A health worker injects a woman during clinical trials for a COVID-19 vaccine at Research Centers of America in Hollywood, Florida, on Sept. 9. Drugmaker Pfizer is expected to seek federal permission to release its COVID-19 vaccine by the end of
0 Comments
As many as 60% of patients with chronic myeloid leukemia (CML) and sustained deep molecular response being treated with long-term tyrosine kinase inhibition remained in treatment-free remission (TFR) after treatment discontinuation, according to results of the LAST trial. Patients who discontinued treatment and remained in TFR reported improvements in fatigue, depression, gastrointestinal upset, sleep and
0 Comments
Lock downs during the pandemic have made life difficult for many. Aside from job loss, restrictions on movement prevent people from interacting personally. The result:  higher rates of social isolation, loneliness and even suicide. One especially vulnerable group is older adults, who may live alone and depend on others for company and support. To address an
0 Comments